Epidemiology of Surfactant Protein-B Deficiency
NCT00014859 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5176
Last updated 2024-04-29
Summary
The purpose of this study is to test the hypothesis that excess, rare, functionally disruptive single nucleotide polymorphisms (SNPs) characterize genes (e.g., the surfactant protein-B gene)(SFTPB) and gene networks (e.g., the pulmonary surfactant metabolic network or other gene networks that regulate alveolar type 2 cell function) associated with increased risk of neonatal respiratory distress syndrome (RDS).
Conditions
- Lung Diseases
- Respiratory Distress Syndrome, Newborn
- Pulmonary Surfactant
- Lung Diseases, Interstitial
Sponsors & Collaborators
-
Washington University School of Medicine
lead OTHER
Principal Investigators
-
F. Sessions Cole, MD · Washington University School of Medicine
Eligibility
- Max Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2001-06-01
- Primary Completion
- 2024-04-26
- Completion
- 2024-04-26
Countries
- United States
Study Locations
More Related Trials
-
Infant Study of Inhaled Saline in Cystic Fibrosis
NCT00709280 ·Status: COMPLETED ·Phase: NA
-
Relationship Between Fungal Colonization and Severe Bronchopulmonary Dysplasia
NCT05152875 ·Status: COMPLETED
-
Viral Pathogenesis of Early Cystic Fibrosis Lung Disease
NCT01973192 ·Status: COMPLETED
-
Determinants of Early Cystic Fibrosis Lung Disease
NCT03579173 ·Status: COMPLETED
-
Prospective Study of Pregnancy in Women With Cystic Fibrosis
NCT04828382 ·Status: ACTIVE_NOT_RECRUITING
-
Benefits and Risks of Newborn Screening for Cystic Fibrosis
NCT00014950 ·Status: COMPLETED ·Phase: NA
-
Genetics of Insulin and Incretins in Cystic Fibrosis
NCT01852448 ·Status: RECRUITING
-
Perceptions of the CF Screening Protocol Incorporating NGS
NCT06299566 ·Status: COMPLETED
-
Zinc Status and Growth in Cystic Fibrosis
NCT04302428 ·Status: COMPLETED
-
sPLA2 in EBC During Acute Chest Syndrome
NCT03250585 ·Status: COMPLETED
-
The Effects of Long Term Inhalation of Hypertonic Saline in Subjects With Cystic Fibrosis
NCT00271310 ·Status: COMPLETED ·Phase: PHASE3
-
Molecular Phenotypes for Cystic Fibrosis Lung Disease
NCT01116414 ·Status: COMPLETED
-
Saline Hypertonic in Preschoolers + CT
NCT02950883 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Utility of Induced Sputum Using Hypertonic Saline to Evaluate Infection and Inflammation in Cystic Fibrosis
NCT00721071 ·Status: COMPLETED ·Phase: PHASE2
-
Using Rheological Methods to Characterize Cystic Fibrosis (CF) Sputum and the Effects of Mucoactive Agents
NCT00758771 ·Status: COMPLETED
-
Effect of Pioglitazone on Inflammation in Cystic Fibrosis
NCT00719381 ·Status: COMPLETED ·Phase: PHASE1
-
Outpatient Antibiotic Treatment for a Cystic Fibrosis Pulmonary Exacerbation
NCT02480270 ·Status: COMPLETED
-
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
NCT04568980 ·Status: COMPLETED
-
Effects of Mycophenolate Mofetil in Cystic Fibrosis Lung Transplant Patients
NCT00908830 ·Status: COMPLETED
-
Using MRI to Observe Lung Changes in Infants With CF Compared to Infants Without CF
NCT01832519 ·Status: COMPLETED
-
Diagnosis and Treatment of Patients With Cystic Fibrosis
NCT00001223 ·Status: TERMINATED
-
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
NCT02109822 ·Status: COMPLETED
-
GEN-FPF: Genetic Exploration of Familial Pulmonary Fibrosis
NCT07251725 ·Status: RECRUITING
-
Pulmonary Vascular Disease in CF
NCT04549077 ·Status: ACTIVE_NOT_RECRUITING
-
Respiratory Function at Preschool Age of Children Detected of Cystic Fibrosis in Neonatal Period
NCT02358798 ·Status: COMPLETED ·Phase: NA